Facebook Linkedin Twitter
Inside Precision Medicine Allogene CAR-T Cancer Trials Placed on Clinical Hold by FDA

Phase II clinical trials (Drug development)

CAR T-Cell Immunotherapy
News & Features

Allogene CAR-T Cancer Trials Placed on Clinical Hold by FDA

0
Neurons sending pulsating electric impulses and communicating with each other. Concept For Neurological Diseases, Tumors And Brain Surgery
News & Features

AI-Guided Drug Repurposing for Treatment of Huntington’s Successful at Phase II

0
Young woman on beach with sunburn, rear view
News & Features

Histone Deacetylation Inhibitor Shows Promise for Treating Basal Cell Carcinoma

0
Secondary tuberculosis infection, illustration
News & Features

Genetic Targets for New Tuberculosis Lung Treatments Identified

0
Lung Cancer
Molecular Dx

KRAS Lung Cancer Drug Reaches Clinic via Accelerated FDA Approval

0
Dividing stem cells (mitosis)
News & Features

Antiviral T Cells Prove Useful for Debilitating Stem Cell Transplant Side Effect

0
The Lab
Coronavirus

“Refined” COVID-19 Vaccine Program of Sanofi and GSK Launches Phase II Trial

0
Wuhan corona virus render
Coronavirus

Moderna Gets FDA Green Light for COVID-19 Vaccine Phase II Trial

0
Inivata, EORTC Partner to Study Liquid Biopsy in Assessing Resistance to Pfizer’s Lorbrena
Molecular Dx

Inivata, EORTC Partner to Study Liquid Biopsy in Assessing Resistance to Pfizer’s Lorbrena

0
Lung cancer, close-up, NSCLC
Molecular Dx

Merck Using PGDx Pan-Cancer Tissue Assay in Combination Therapy Trial

0
1...456Page 5 of 6

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine